{
    "doi": "https://doi.org/10.1182/blood.V112.11.4838.4838",
    "article_title": "Caspofungin for the Treatment of Candidemia in patients with Hematological Malignancies ",
    "article_date": "November 16, 2008",
    "session_type": "Immunodeficiency, Including HIV and Other Infections",
    "abstract_text": "Objective: To evaluate the efficacy of Caspofungin in patients with hematological malignancies (HM) and candidemia Design: The study was prospectively conducted in 11 Hematology Divisions in a tertiary care or university hospital setting.; neutropenic hematological patients with clinical evidence of infection and a positive blood culture for Candida were enrolled. Patients and results: Between January 2005 and November 2007, 38 episodes of candidemia among patients with HM were registered. Among these, 24 eligible neutropenic patients, collected in 8/11 participating centers, were evaluated. All these patients had received chemotherapy for their underlying hematological diseases: acute myeloid leukemia (AML) in 11 patients (46%); non Hodgkin\u2019s lymphoma (NHL) in 6 patients (25%); acute lymphoblastic leukemia (ALL) in 4 patients (16%); multiple myeloma (MM) in 2 patients (8%); chronic lymphoblastic leukemia (CLL) in 1 patient. In 11 patients (46%) the infection onset after a HSCT procedure (7 allogeneic and 4 autologous). Before the infection onset, all patients were neutropenic (ANC<0.5\u00d710 9 /l) for a median average of 12 days (range 2\u201341). Candidemia diagnosis was made after a median time of 3 days from the onset of fever. Candida isolated species were: C.albicans 46%, C. parapsilosis 17%, C. krusei 12.5%, C. tropicalis in 8%, C. lusitanae , C. guillermondii, C. dubliniensis, C. famata in 4% of patients each. Caspofungin at standard dosage was the first-line therapy in 17 pts (71%); in the other 7 pts, previous antifungal therapy (4 L-AmB, 1 itraconazole, 1 fluconazole, 1 voriconazole) was changed to Caspofungin at candidemia diagnosis after no more than 48 hours of treatment. The median duration of Caspofungin therapy was 12 days (range 3\u201326). No side effects were registered. A complete response to therapy of 58% was obtained. At 30 days following candidemia onset, 11 pts had died (41%), but the candidemia was responsible for the mortality in only 6 pts (overall attributable mortality 25%). Conclusions: Our data confirm the efficacy of Caspofungin in the treatment of neutropenic pts with HM and concomitant candidemia as well as it was reported for non hematological subgroups. Caspofungin was well tolerated also in very compromised pts.",
    "topics": [
        "candidemia",
        "caspofungin",
        "hematologic neoplasms",
        "brachial plexus neuritis",
        "neutropenia",
        "infections",
        "acute lymphocytic leukemia",
        "adverse effects",
        "amphotericin b",
        "antifungal agents"
    ],
    "author_names": [
        "Luana Fianchi",
        "Rosa Fanci",
        "Anna Candoni",
        "Morena Caira",
        "Caterina Giovanna Valentini",
        "Brunella Posteraro",
        "Monica Morselli",
        "Giuliana Farina",
        "Maria Enza Mitra",
        "Massimo Offidani",
        "Maurizio Sanguinetti",
        "Maria Elena Tosti",
        "Annamaria Nosari",
        "Pierluigi Viale",
        "Giuseppe Leone",
        "Livio Pagano"
    ],
    "author_dict_list": [
        {
            "author_name": "Luana Fianchi",
            "author_affiliations": [
                "Istituto di Ematologia, Universita\u0300 Cattolica Sacro Cuore, Rome, Italy"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Rosa Fanci",
            "author_affiliations": [
                "Firenze University"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Candoni",
            "author_affiliations": [
                "Hematology, Udine University, Italy"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Morena Caira",
            "author_affiliations": [
                "Istituto di Ematologia, Universita\u0300 Cattolica Sacro Cuore, Rome, Italy"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caterina Giovanna Valentini",
            "author_affiliations": [
                "Istituto di Ematologia, Universita\u0300 Cattolica Sacro Cuore, Rome, Italy"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Brunella Posteraro",
            "author_affiliations": [
                "Istituto di Microbiologia, Universita\u0300 Cattolica Sacro Cuore, Roma, Italy"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Morselli",
            "author_affiliations": [
                "Istituto di Ematologia, Policlinico, Modena, Italy"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuliana Farina",
            "author_affiliations": [
                "Ematologia, Universita\u0300 Cattolica Sacro Cuore, Campobasso, Italy"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Enza Mitra",
            "author_affiliations": [
                "Palermo University"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimo Offidani",
            "author_affiliations": [
                "Clinica di Ematologia, Ancona, Italy"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maurizio Sanguinetti",
            "author_affiliations": [
                "Istituto di Microbiologia, Universita\u0300 Cattolica Sacro Cuore, Roma, Italy"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Elena Tosti",
            "author_affiliations": [
                "Epidemiologia Clinica Department, Istituto Superiore della Sanita\u0300, Italy"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Annamaria Nosari",
            "author_affiliations": [
                "Dept. of Hematology, Niguarda Ca\u2019 Granda Hospital, Milano, Italy"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pierluigi Viale",
            "author_affiliations": [
                "Clinic of Infectious Diseases, Udine University, Italy"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Leone",
            "author_affiliations": [
                "Istituto di Ematologia, Universita\u0300 Cattolica Sacro Cuore, Rome, Italy"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Livio Pagano",
            "author_affiliations": [
                "Istituto di Ematologia, Universita\u0300 Cattolica Sacro Cuore, Rome, Italy"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-09T21:35:02",
    "is_scraped": "1"
}